Skip to main content

Unable to load price data. Sorry.


Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: No stars

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Unable to load market data for this Ticker. Sorry.



How do you think NASDAQ:BRLI will perform against the market?

Add Stock to CAPS Watchlist

All Players

249 Outperform
17 Underperform

All-Star Players

32 Outperform
3 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:BRLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

debster863 (< 20)
Submitted March 04, 2011

I work in Healthcare, this lab has just come into our organization, we currently use labcorp and quest. I started researching bio-referance and it seems a strong company. lots of positives (growth, gendx, cancer research etc). still researching but… More

ac11166 (< 20)
Submitted August 29, 2006

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

Recent Community Commentary

Read the most recent pitches from players about BRLI.


Member Avatar MWillou (53.80) Submitted: 12/20/2013 9:30:14 AM : Outperform Start Price: $25.20 NASDAQ:BRLI Score: -43.40

Near-term ACA pressure will negatively impact BRLI and the other healthcare provider (health system, clinical labs) companies. Several years out, I expect BRLI to increase because it performs esoteric tests that DGX and LH do not. Game changer in lab industry is Theranos, who is not doing esoteric testing right now.


Member Avatar tecramer (< 20) Submitted: 9/2/2013 8:33:18 PM : Outperform Start Price: $29.29 NASDAQ:BRLI Score: -79.46

This small player has lots of room to grow with some innovative tests and interesting acquisitions that should help expand market share along with geographic coverage.


Member Avatar cheezyches (93.58) Submitted: 4/16/2013 8:19:16 AM : Outperform Start Price: $23.76 NASDAQ:BRLI Score: -63.27

BRLI is operating in a long-term trend of increasing health care. It's financial results have shown robust growth trajectories over the last few years. I do not see any reason for this trend to change.


Find the members with the highest scoring picks in BRLI.

Score Leader


avscaptain (90.49) Score: +134.56

The Score Leader is the player with the highest score across all their picks in BRLI.

Member Name Member
Call Time
Score Commentary
pnouri 81.72 7/27/2010 Underperform 5Y $21.79 +58.83% +191.11% +132.28 0 Comment
williamscaps 22.74 10/25/2010 Underperform 5Y $22.99 +50.54% +173.77% +123.23 1 Comment
buckler9483 31.84 9/8/2010 Underperform 5Y $19.63 +76.31% +195.24% +118.93 0 Comment
setonmiddlesch < 20 1/28/2009 Underperform 1Y $12.63 +174.03% +284.63% +110.60 0 Comment
jaystox < 20 6/20/2012 Underperform 5Y $25.63 +35.04% +140.62% +105.58 0 Comment
FoolNMe2 36.44 5/27/2011 Underperform 3Y $23.97 +44.39% +144.73% +100.34 0 Comment
marketmomentum 22.66 8/11/2009 Underperform 3W $14.93 +131.89% +226.32% +94.43 1 Comment
NeedhelpAlways62 < 20 4/27/2009 Underperform 3M $11.68 +196.32% +285.11% +88.79 0 Comment
bigreenmountain 82.39 1/23/2007 Outperform 3Y $11.22 +208.60% +143.63% +64.97 0 Comment
dsks68 < 20 8/28/2006 Outperform 3Y $10.46 +230.88% +168.46% +62.42 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BRLI.